EU Parliament to vote on a new patentability exclusion thereby re-opening the Biotech Patent Directive
Biotechnology has been identified as one of the key technologies with a significant potential to boost Europe’s competitiveness whilst providing solutions that contribute to reaching the EU’s sustainability ambitions. A new Regulation for plants produced by certain New Genomic Techniques (NGT), such as targeted gene editing, would represent an important milestone in fostering the biotechnology sector in Europe, although it has been contentious to what extent such genetically modified organisms should be permitted to be released into nature.